Free Trial

Xylem (NYSE:XYL) Receives "Buy" Rating from UBS Group

Xylem logo with Business Services background

Key Points

  • UBS Group has raised its price target for Xylem (NYSE:XYL) from $164.00 to $168.00, indicating a potential upside of 16.09% from the stock's previous close.
  • Other analysts have also updated their ratings on Xylem, with Royal Bank Of Canada setting a new target of $147.00 and Citigroup increasing theirs to $152.00, while Stifel Nicolaus has the highest target at $175.00.
  • Xylem reported better-than-expected earnings with $1.26 earnings per share (EPS) for the last quarter, exceeding forecasts and showing a year-over-year revenue increase of 6.1%.
  • Need Better Tools to Track Xylem? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Xylem (NYSE:XYL - Get Free Report)'s stock had its "buy" rating restated by research analysts at UBS Group in a report issued on Tuesday, MarketBeat.com reports. They currently have a $168.00 price target on the industrial products company's stock, up from their previous price target of $164.00. UBS Group's target price indicates a potential upside of 16.95% from the company's current price.

Several other equities analysts also recently issued reports on XYL. Stifel Nicolaus boosted their price objective on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. JPMorgan Chase & Co. initiated coverage on Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 price target for the company. Royal Bank Of Canada raised their price target on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a report on Wednesday, April 30th. Robert W. Baird reduced their price objective on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Finally, Citigroup reiterated a "buy" rating and issued a $152.00 target price (up previously from $137.00) on shares of Xylem in a research report on Monday, July 14th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $151.57.

Check Out Our Latest Report on Xylem

Xylem Price Performance

Shares of NYSE XYL opened at $143.66 on Tuesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The firm has a market capitalization of $34.97 billion, a PE ratio of 37.31, a P/E/G ratio of 2.49 and a beta of 1.11. Xylem has a 1-year low of $100.47 and a 1-year high of $145.33. The business's fifty day moving average price is $130.54 and its two-hundred day moving average price is $124.81.

Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.15 by $0.11. The business had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company's quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.09 earnings per share. On average, research analysts expect that Xylem will post 4.65 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of XYL. Valley National Advisers Inc. grew its stake in Xylem by 84.9% during the 1st quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after acquiring an additional 101 shares in the last quarter. Perkins Coie Trust Co acquired a new stake in shares of Xylem during the first quarter worth approximately $27,000. Maseco LLP purchased a new position in Xylem during the second quarter valued at approximately $31,000. Center for Financial Planning Inc. increased its stake in Xylem by 52.0% in the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after buying an additional 91 shares during the period. Finally, ST Germain D J Co. Inc. lifted its position in Xylem by 950.0% in the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company's stock worth $33,000 after buying an additional 228 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.

Xylem Company Profile

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

Analyst Recommendations for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines